Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1999View

Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

CBChandra P. BelaniPennsylvania State UniversityCKChristine M. KearnsFleet Science CenterEZEleanor G. ZuhowskiRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Belani et al. (1999) studied this question.

synapsesocial.com/papers/6a1ca1595a7763abe78987abhttps://doi.org/10.1200/jco.1999.17.2.676
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results1993 · 339 citations
  2. 2Prediction of Creatinine Clearance from Serum Creatinine2008 · 15,448 citations
  3. 3Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.1995 · 304 citations
  4. 4Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.1997 · 183 citations